FDA Authorizes Marketing of New Implant to Repair a Torn ACL
WASHINGTON, D.C. — The U.S. Food and Drug Administration has granted marketing authorization—under the De Novo premarket review pathway—for an anterior cruciate ligament (ACL) implant, intended to serve as an …
Read More